
Two Onc Docs
This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for health care providers.*
Episodes
159 episodes
Localized Kidney Cancer x Uromigos 2025 UPDATES (Part 1)
Today’s episode we will cover 2025 updates for localized renal cell carcinoma (RCC) with Dr. Tom Powles and Dr. Brian Rini from the urologic oncology podcast Uromigos! We will discuss risk factors, the presentation, staging, and treatment optio...
•
Season 4
•
Episode 18
•
20:18

Cervical Cancer 2025 UPDATE
This week’s episode will be focusing on Cervical Cancer with some updates since we last released this topic in 2022. We will go over important details on prevention, risk factors, diagnosis & treatment.
•
Season 4
•
Episode 17
•
11:14

Oncologic Emergencies 2025 Update
This week’s episode is an update on a must-know topics both for new fellows & residents. We will go over clinically important oncologic emergencies including brain metastases, hypercalcemia of malignancy, cord compression and SVC syndrome.&...
•
Season 4
•
Episode 17
•
12:00

ASCO 2025 Plenary - MATTERHORN
This week’s episode will be focusing on one of the GI plenary session abstracts presented at the ASCO Annual Meeting 2025, the MATTERHORN trial: phase 3 durvalumab + FLOT which is 5FU leucovorin, oxaliplatin and docetaxel in resectable ga...
•
Season 4
•
Episode 16
•
12:27

Preparing for Fellowship 101
This week’s episode will be focusing on how to prepare for the start of heme/onc fellowship! We will go over some general advice on how to succeed, study tips and resources we used throughout fellowship as well as some tips on how t...
•
Season 4
•
Episode 16
•
15:52

ASCO 2025 Plenary: SERENA-6
This week’s episode will be focusing on one of the 2025 plenary sessions: SERENA-6, Camizestrant, a novel selective estrogen receptor degrader (SERD) + CDK 4/6i for tx of emergent ESR1 during 1L endocrine-based therapy + ahead of progression in...
•
Season 4
•
Episode 15
•
12:33

Ovarian Cancer 2025 UPDATE
This week’s episode will be focusing on Ovarian Cancer with 2025 updates since we last covered this topic in 2022. We will go over all important details on the risk factors, presentation, diagnosis, staging & treatment options for both loca...
•
Season 4
•
Episode 14
•
12:58

ASCO Annual Meeting 2025 GU Updates
This week’s episode will be focusing on exciting data in GU presented at the 2025 ASCO Annual Meeting in prostate (including prognostication of PSA response in mCSPC, AMPLITUDE - PARPi in mCSPC), RCC (including updates in KN-564, CM-214 and PDI...
•
Season 4
•
Episode 14
•
12:59

ASCO 2025 Preview
This week’s episode will be focusing on exciting data to come at the ASCO Annual Meeting 2025 starting with the plenary sessions, then a special focus on the GU abstracts, including prostate CA, renal cell carcinoma, bladder CA, and a quick sho...
•
Season 4
•
Episode 13
•
11:28

Hepatocellular Carcinoma (HCC) 2025 UPDATE
This week’s episode will be focusing on hepatocellular carcinoma (HCC). We will go over important details on assessing liver function, staging of HCC and loco-regional as well as systemic treatment options for HCC.
•
Season 4
•
Episode 12
•
15:51

Stem Cell Transplant (SCT) Part 2 x Dr. Jeff Auletta 2025 UPDATE
This week’s episode will be focusing on Hematopoietic Stem Cell Transplant. We welcome our guest Dr. Jeff Auletta, Senior Vice President, National Marrow Donor Program, and Chief Scientific Director,Center for International Blood and Marr...
•
Season 4
•
Episode 11
•
29:22

Stem Cell Transplant (SCT) Part 1 x Dr. Jeff Auletta 2025 UPDATE
This week’s episode will be focusing on Hematopoietic Stem Cell Transplant. We welcome our guest Dr. Jeff Auletta, Senior Vice President, National Marrow Donor Program, and Chief Scientific Director,Center for International Blood and Marr...
•
Season 4
•
Episode 10
•
26:50

Testicular Cancer 2025 UPDATE Part 2 (Non-Seminoma)
This week’s episode is part 2 of testicular cancer 2025 updates. We had the honor of interviewing Dr. Larry Einhorn a true legend when it comes to the management of non-seminoma last year, released 4/22/2024, but today, we will be repeating a q...
•
Season 4
•
Episode 9
•
10:41

Testicular Cancer 2025 UPDATE Part 1 (Seminoma)
This week’s episode is part 1 of testicular cancer 2025 updates. We had the honor of interviewing Dr. Larry Einhorn a true legend when it comes to the management of testicular CA last year, released in April 2024, but today, we will be repeatin...
•
Season 4
•
12:01

Chronic Lymphocytic Leukemia (CLL) 2025 UPDATE
This week’s episode will be focusing on an update of CLL. We will go over important details on the presentation, diagnosis, prognostic factors, and treatment options for initial and refractory disease, as well as key toxicities.
•
Season 4
•
12:42

Metastatic Prostate Cancer x Dr. Charles Ryan 2025 UPDATE
We are so excited to welcome back Dr. Charles (Chuck) Ryan for our 2025 prostate cancer updates. Dr. Ryan is an internationally recognized GU oncologist and prostate cancer expert, seeing patients at MSK in NYC, and co-host of the podcast 'The ...
•
Season 4
•
Episode 7
•
34:53

Localized Prostate Cancer x Dr. Charles Ryan 2025 UPDATE
We are so excited to welcome Dr. Charles (Chuck) Ryan for our 2025 prostate cancer updates. Dr. Ryan is an internationally recognized GU oncologist and prostate cancer expert, seeing patients at Memorial Sloan Kettering in NYC. This...
•
Season 4
•
Episode 7
•
35:49

Metastatic Colon Cancer 2025 UPDATE
Today’s episode is focusing on what you need to know regarding metastatic colon cancer. This will include the need to know about molecular studies, treatment, and surgery for oligometastatic disease. There has been three breakthroughs since we ...
•
Season 4
•
Episode 6
•
23:45

Localized Colon Cancer 2025 UPDATE
Today’s episode is focusing on what you need to know regarding early stage colorectal cancer (CRC) as of 2025. The last time we covered this topic was in 2023 and things continue to change. We will go over all the important details on the diagn...
•
Season 4
•
Episode 6
•
40:25

Multiple Myeloma 2025 x Dr. Vincent Rajkumar Part 2
We are so honored to welcome back Dr. S. Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He is also Editor-In-Chief of Blood Cancer Journal and the Chairperson of the Board of the International Myeloma Founda...
•
Season 4
•
Episode 5
•
19:13

ASCO GU 2025 Takeaways
Today we will be discussing a few of the exciting abstracts presented at ASCO GU (Feb 13-15 2025) for prostate CA (TALAPRO-2), bladder CA (EV-302, CM-274, NIAGARA), and RCC (COSMIC-313, KIM-1).
•
Season 4
•
Episode 6
•
13:22

ASCO GU 2025 Preview
Today we will be discussing exciting data to come at ASCO GU (Feb 13-15 2025) in terms of research for prostate CA, bladder CA, RCC and other rarer GU tumors.
•
Season 4
•
Episode 5
•
10:46

Multiple Myeloma 2025 x Dr. Vincent Rajkumar Part 1
We are so honored to welcome Dr. S. Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He is also Editor-In-Chief of Blood Cancer Journal and the Chairperson of the Board of the International Myeloma Foundation....
•
Season 4
•
Episode 4
•
17:34

Small Cell Lung Cancer 2025 x Dr. Stephen Liu Part 2
This week’s episode will be focusing on additional details for Extensive Stage Small Cell Lung Cancer (SCLC), options for relapsed/refractory disease & advice for trainees. We are so excited to welcome back Dr. Stephen Liu international exp...
•
Season 4
•
Episode 5
•
34:24

Small Cell Lung Cancer 2025 x Dr. Stephen Liu Part 1
This week’s episode will be focusing on Small Cell Lung Cancer (SCLC). We will go all the important details on risk factors, diagnostic work-up, staging and treatment of both locoregional and metastatic SCLC. We are so excited to welcome Dr. St...
•
Season 4
•
Episode 3
•
23:32
